Hospital
Topeka Hospital, LLC
Topeka Hospital, LLC was paid $3.94M by Medicaid between Jan 2018 and Nov 2024, across 156 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
33Billing provider infoTOPEKA HOSPITAL, LLC
TOPEKA, KS 66606
TOPEKA, KS 66606
33aNPI1912423260assigned 08/18/2017
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.94M
24GClaims249,728
24DCodes billed156
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Kansas
Rank by total paid#8 of 48
Median peer was paid$461K
This provider vs. median8.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PETROVICH, STEPHEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 43,472 | $682K | |
| 2019 | 34,892 | $614K | |
| 2020 | 34,298 | $546K | |
| 2021 | 39,630 | $702K | |
| 2022 | 39,658 | $610K | |
| 2023 | 35,769 | $412K | |
| 2024incomplete | 22,009 | $370K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 21,126 | 19,824 | $852K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 18,000 | 16,676 | $706K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.8% | 11,296 | 10,471 | $385K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5.7% | 2,420 | 2,309 | $225K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.7% | 12,951 | 11,953 | $223K |
| 96375 | Therapeutic injection; each additional sequential IV push | 5.7% | 7,742 | 6,814 | $223K |
| 80053 | Comprehensive metabolic panel | 4.1% | 19,190 | 16,727 | $162K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.0% | 30,608 | 26,740 | $119K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.8% | 11,703 | 9,140 | $110K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.5% | 2,349 | 2,282 | $99K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.5% | 2,330 | 2,267 | $99K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.7% | 840 | 373 | $65K |
144 more codes
| 84484 | 1.5% | 6,941 | $57K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.2% | 4,304 | $47K |
| 81001 | 1.0% | 13,077 | $41K | |
| 71045 | Radiologic examination, chest; single view | <1% | 5,906 | $37K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,027 | $35K |
| 80047 | <1% | 2,219 | $32K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 104 | $31K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 551 | $31K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 362 | $30K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,239 | $23K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 546 | $20K |
| 83690 | <1% | 2,916 | $16K | |
| 93299 | <1% | 388 | $15K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 523 | $15K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 393 | $12K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 226 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,116 | $11K |
| 83615 | <1% | 1,887 | $10K | |
| 87400 | <1% | 1,094 | $9K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 137 | $9K |
| 81025 | <1% | 1,013 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 289 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 645 | $6K |
| 86780 | <1% | 451 | $6K | |
| 0002A | <1% | 356 | $5K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 183 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 347 | $5K |
| 84702 | <1% | 483 | $5K | |
| 85027 | <1% | 749 | $5K | |
| S9443 | Lactation classes, non-physician provider, per session | <1% | 668 | $4K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 550 | $4K |
| 0001A | <1% | 391 | $4K | |
| G0378 | Hospital observation service, per hour | <1% | 150 | $4K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 97 | $4K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 100 | $4K |
| 87507 | <1% | 13 | $4K | |
| 83735 | <1% | 879 | $3K | |
| 93296 | <1% | 354 | $3K | |
| 84703 | <1% | 407 | $3K | |
| 80061 | Lipid panel | <1% | 422 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 56 | $3K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 157 | $3K |
| 87653 | <1% | 82 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 279 | $3K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 103 | $3K |
| 87070 | <1% | 371 | $3K | |
| 59025 | Fetal non-stress test | <1% | 73 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 436 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 26,450 | $3K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 577 | $2K |
| 82950 | <1% | 345 | $2K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 28 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,439 | $2K |
| 83880 | <1% | 206 | $2K | |
| 82607 | <1% | 227 | $2K | |
| 85610 | <1% | 762 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 162 | $2K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,884 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,050 | $2K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 31 | $2K |
| 84145 | <1% | 143 | $2K | |
| 86850 | <1% | 195 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 162 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 89 | $1K |
| 87650 | <1% | 115 | $1K | |
| 82947 | <1% | 559 | $1K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 13 | $1K |
| 87486 | <1% | 104 | $1K | |
| 87581 | <1% | 104 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 54 | $978.52 |
| 85652 | <1% | 313 | $944.66 | |
| 96376 | <1% | 56 | $931.65 | |
| 87420 | <1% | 78 | $909.02 | |
| 82570 | <1% | 146 | $907.35 | |
| 80055 | <1% | 14 | $858.98 | |
| 84439 | <1% | 118 | $845.64 | |
| 87808 | <1% | 66 | $786.58 | |
| 86901 | <1% | 145 | $723.54 | |
| 80076 | <1% | 119 | $649.29 | |
| 86900 | <1% | 145 | $574.19 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 52 | $562.08 |
| 85004 | <1% | 293 | $533.11 | |
| 87340 | <1% | 48 | $532.44 | |
| 82728 | <1% | 47 | $503.22 | |
| 86140 | <1% | 118 | $502.53 | |
| 82565 | <1% | 117 | $491.27 | |
| 83605 | <1% | 86 | $486.49 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 15 | $433.09 |
| 83655 | <1% | 28 | $402.09 | |
| 86762 | <1% | 48 | $394.55 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 188 | $386.67 |
| 87077 | <1% | 68 | $372.06 | |
| 87186 | <1% | 62 | $363.12 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 814 | $359.19 |
| 83540 | <1% | 88 | $332.72 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 283 | $328.60 |
| 82310 | <1% | 42 | $325.36 | |
| 87428 | <1% | 15 | $318.60 | |
| J2704 | Injection, propofol, 10 mg | <1% | 727 | $287.88 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 209 | $283.62 |
| 82340 | <1% | 30 | $270.68 | |
| 83550 | <1% | 38 | $246.98 | |
| 74018 | <1% | 35 | $242.72 | |
| 81003 | <1% | 259 | $229.11 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 76 | $182.65 |
| 86803 | <1% | 14 | $159.58 | |
| 87210 | <1% | 31 | $158.14 | |
| 84436 | <1% | 13 | $119.76 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,977 | $117.33 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 77 | $114.12 |
| 86592 | <1% | 19 | $110.90 | |
| 87147 | <1% | 21 | $108.96 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 60 | $107.74 |
| 82746 | <1% | 12 | $103.77 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 264 | $95.80 |
| 84550 | <1% | 28 | $95.60 | |
| 82962 | <1% | 37 | $63.08 | |
| 87205 | <1% | 28 | $60.05 | |
| 85046 | <1% | 14 | $55.56 | |
| 82043 | <1% | 12 | $51.27 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 67 | $49.45 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 30 | $27.88 |
| 85730 | <1% | 12 | $26.66 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 47 | $15.04 |
| 82044 | <1% | 29 | $13.35 | |
| 0352U | <1% | 79 | $13.20 | |
| 87040 | <1% | 22 | $11.89 | |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | <1% | 109 | $9.90 |
| J3490 | Unclassified drugs | <1% | 22 | $9.41 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 64 | $7.68 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 12 | $6.24 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,219 | $4.12 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 16 | $2.26 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 12 | $0.65 |
| 36416 | 0% | 137 | $0.00 | |
| G0379 | Direct admission of patient for hospital observation care | 0% | 98 | $0.00 |
| A9270 | Non-covered item or service | 0% | 554 | $0.00 |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 0% | 33 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 71 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 85 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 14 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 16 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 40 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPETROVICH, STEPHEN (EVP)
Parent organizationTOPEKA HEALTH SYSTEM, LLC
| Provider | Location | Paid |
|---|---|---|
| Lovelace Health System, LLC | Albuquerque, NM | $57.71M |
| Lovelace Health System LLC | Albuquerque, NM | $45.27M |
| Southwest Medical Associates, LLC | Albuquerque, NM | $41.40M |
| Lovelace Health System, LLC | Albuquerque, NM | $31.24M |
| Lovelace Health System LLC | Roswell, NM | $20.13M |
| Jacksonville Hospital LLC | Jacksonville, TX | $9.41M |
| Henderson Hospital, LLC | Henderson, TX | $8.52M |
| Athens Hospital, LLC | Athens, TX | $8.32M |
| Etmc Physician Group INC. | Tyler, TX | $8.03M |
| Tyler Regional Hospital LLC | Tyler, TX | $7.94M |
| Lovelace Unm Rehabilitation Hospital LLC | Albuquerque, NM | $6.30M |
| Pocatello Hospital LLC | Pocatello, ID | $6.11M |
| Jacksonville Hospital LLC | Jacksonville, TX | $5.93M |
| Ahs Pryor Hospital, LLC | Pryor, OK | $5.61M |
| Bsa Hospital LLC | Amarillo, TX | $4.96M |
| Pittsburg Hospital LLC | Pittsburg, TX | $4.83M |
| Ahs Claremore Regional Hospital, LLC. | Claremore, OK | $4.81M |
| Ahs Henryetta Hospital LLC | Henryetta, OK | $4.27M |
| Pittsburg Hospital LLC | Pittsburg, TX | $3.98M |
| Ahs Pryor Hospital, LLC | Pryor, OK | $3.76M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.